245 related articles for article (PubMed ID: 5032520)
21. Relationships between carrier-mediated transport of folate compounds by L1210 leukemia cells: evidence for multiplicity of entry routes with different kinetic properties expressed in plasma membrane vesicles.
Yang CH; Dembo M; Sirotnak FM
J Membr Biol; 1983; 75(1):11-20. PubMed ID: 6887234
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model.
Inoue K; Nakai Y; Ueda S; Kamigaso S; Ohta KY; Hatakeyama M; Hayashi Y; Otagiri M; Yuasa H
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G660-8. PubMed ID: 18174275
[TBL] [Abstract][Full Text] [Related]
23. Iron transport mechanisms in reticulocytes and mature erythrocytes.
Hodgson LL; Quail EA; Morgan EH
J Cell Physiol; 1995 Feb; 162(2):181-90. PubMed ID: 7822429
[TBL] [Abstract][Full Text] [Related]
24. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Spinella MJ; Brigle KE; Sierra EE; Goldman ID
J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
[TBL] [Abstract][Full Text] [Related]
25. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells.
Sirotnak FM; Donsbach RC
Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750
[No Abstract] [Full Text] [Related]
26. Interactions between 7-hydroxymethotrexate and methotrexate at the cellular level in the Ehrlich ascites tumor in vitro.
Fabre G; Matherly LH; Fabre I; Cano JP; Goldman ID
Cancer Res; 1984 Mar; 44(3):970-5. PubMed ID: 6692419
[TBL] [Abstract][Full Text] [Related]
27. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
[TBL] [Abstract][Full Text] [Related]
28. Relationship of reduced folate changes to inhibition of DNA synthesis induced by methotrexate in L1210 cells in vivo.
Priest DG; Bunni M; Sirotnak FM
Cancer Res; 1989 Aug; 49(15):4204-9. PubMed ID: 2743307
[TBL] [Abstract][Full Text] [Related]
29. Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3':5'-monophosphate in the Ehrlich ascites tumor.
White JC; Carchman RA; Fry DW; Goldman ID
Cancer Res; 1980 Jul; 40(7):2400-4. PubMed ID: 6155994
[TBL] [Abstract][Full Text] [Related]
30. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
[TBL] [Abstract][Full Text] [Related]
31. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
[TBL] [Abstract][Full Text] [Related]
32. Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells.
Zhao R; Seither R; Brigle KE; Sharina IG; Wang PJ; Goldman ID
J Biol Chem; 1997 Aug; 272(34):21207-12. PubMed ID: 9261128
[TBL] [Abstract][Full Text] [Related]
33. The relationship among transport, intracellular binding, and inhibition of RNA synthesis by actinomycin D in Ehrlich ascites tumor cells in vitro.
Bowen D; Goldman ID
Cancer Res; 1975 Nov; 35(11 Pt 1):3054-60. PubMed ID: 1182700
[TBL] [Abstract][Full Text] [Related]
34. Evidence for transfer of folate compounds by a specialized erythrocyte membrane system.
Branda RF; Anthony BK
J Lab Clin Med; 1979 Aug; 94(2):354-60. PubMed ID: 222854
[TBL] [Abstract][Full Text] [Related]
35. Transport of folate compounds by leukemic cells. Evidence for a single influx carrier for methotrexate, 5-methyltetrahydrofolate, and folate in CCRF-CEM human lymphoblasts.
Henderson GB; Tsuji JM; Kumar HP
Biochem Pharmacol; 1987 Sep; 36(18):3007-14. PubMed ID: 3477231
[TBL] [Abstract][Full Text] [Related]
36. Similar characteristics of folate analogue transport in vitro in contrast to varying dihydrofolate reductase levels in epithelial cells at different stages of maturation in mouse small intestine.
Sirotnak FM; Moccio DM; Yang CH
Cancer Res; 1984 Nov; 44(11):5204-11. PubMed ID: 6488181
[TBL] [Abstract][Full Text] [Related]
37. Similar specificity of membrane transport for folate analogues and their metabolites by murine and human tumor cells: a clinically directed laboratory study.
Moccio DM; Sirotnak FM; Samuels LL; Ahmed T; Yagoda A; DeGraw JI; Piper JR
Cancer Res; 1984 Jan; 44(1):352-7. PubMed ID: 6690047
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the transport mechanism for methotrexate in L1210 mouse leukemia cells.
Henderson GB
Prog Clin Biol Res; 1983; 132B():415-23. PubMed ID: 6634763
[TBL] [Abstract][Full Text] [Related]
39. Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells.
Henderson GB; Tsuji JM
Biochim Biophys Acta; 1990 Jan; 1051(1):60-70. PubMed ID: 2297542
[TBL] [Abstract][Full Text] [Related]
40. Folate transport.
Rosenberg IH; Zimmerman J; Selhub J
Chemioterapia; 1985 Oct; 4(5):354-8. PubMed ID: 3907863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
